DE69709722D1 - Mikrokugeln aus polysaccharid zur pulmonaren wirkstoffabgabe - Google Patents
Mikrokugeln aus polysaccharid zur pulmonaren wirkstoffabgabeInfo
- Publication number
- DE69709722D1 DE69709722D1 DE69709722T DE69709722T DE69709722D1 DE 69709722 D1 DE69709722 D1 DE 69709722D1 DE 69709722 T DE69709722 T DE 69709722T DE 69709722 T DE69709722 T DE 69709722T DE 69709722 D1 DE69709722 D1 DE 69709722D1
- Authority
- DE
- Germany
- Prior art keywords
- polysaccharide
- active substance
- substance delivery
- microspheres made
- pulmonary active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9606188.2A GB9606188D0 (en) | 1996-03-23 | 1996-03-23 | Pollysaccharide microspheres for the pulmonary delivery of drugs |
PCT/GB1997/000808 WO1997035562A1 (en) | 1996-03-23 | 1997-03-24 | Polysaccharide microspheres for the pulmonary delivery of drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69709722D1 true DE69709722D1 (de) | 2002-02-21 |
DE69709722T2 DE69709722T2 (de) | 2002-08-14 |
Family
ID=10790945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69709722T Expired - Fee Related DE69709722T2 (de) | 1996-03-23 | 1997-03-24 | Mikrokugeln aus polysaccharid zur pulmonaren wirkstoffabgabe |
Country Status (14)
Country | Link |
---|---|
US (1) | US20010007665A1 (de) |
EP (1) | EP0895473B1 (de) |
JP (1) | JP2000510100A (de) |
AT (1) | ATE209030T1 (de) |
AU (1) | AU718593B2 (de) |
CA (1) | CA2250053A1 (de) |
DE (1) | DE69709722T2 (de) |
DK (1) | DK0895473T3 (de) |
ES (1) | ES2168609T3 (de) |
GB (2) | GB9606188D0 (de) |
NO (1) | NO984376D0 (de) |
NZ (1) | NZ331359A (de) |
PT (1) | PT895473E (de) |
WO (1) | WO1997035562A1 (de) |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US5902844A (en) * | 1998-02-02 | 1999-05-11 | Applied Analytical Industries, Inc. | Spray drying of pharmaceutical formulations containing amino acid-based materials |
CA2231968A1 (en) * | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Method of producing a nicotine medicament |
ATE270097T1 (de) * | 1998-04-09 | 2004-07-15 | Celanese Ventures Gmbh | Partikulärer wirkstoffträger für die pulmonale applikation |
US6284282B1 (en) | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
AU747231B2 (en) * | 1998-06-24 | 2002-05-09 | Alkermes, Inc. | Large porous particles emitted from an inhaler |
US6451349B1 (en) | 1998-08-19 | 2002-09-17 | Quadrant Healthcare (Uk) Limited | Spray-drying process for the preparation of microparticles |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
ES2207867T3 (es) * | 1998-12-11 | 2004-06-01 | Pharmachemie B.V. | Preparacion farmaceutica para inhalacion de un opioide. |
DE69936268T2 (de) * | 1999-03-05 | 2008-02-14 | Chiesi Farmaceutici S.P.A. | Verbesserte pulverförmige pharmazeutische Zusammensetzungen zur Verwendung in Trockenpulverinhalatoren |
CA2367131C (en) | 1999-04-05 | 2007-07-03 | Solomon S. Steiner | Methods for fine powder formation |
US7090831B1 (en) | 1999-04-14 | 2006-08-15 | Smithkline Beecham Corporation | Pharmaceutical aerosol formulation |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
GB0004827D0 (en) * | 2000-02-29 | 2000-04-19 | Quadrant Holdings Cambridge | Compositions |
JP2003525946A (ja) | 2000-03-08 | 2003-09-02 | マサチューセッツ インスティテュート オブ テクノロジー | ヘパリナーゼiiiおよびその使用 |
US8460367B2 (en) | 2000-03-15 | 2013-06-11 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US7037332B2 (en) | 2000-03-15 | 2006-05-02 | Orbus Medical Technologies, Inc. | Medical device with coating that promotes endothelial cell adherence |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
ES2324701T3 (es) | 2000-09-12 | 2009-08-13 | Massachusetts Institute Of Technology | Metodos y productos relacionados con heparina de peso molecular bajo. |
US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
AU2440802A (en) * | 2000-10-18 | 2002-04-29 | Massachusetts Inst Technology | Methods and products related to pulmonary delivery of polysaccharides |
US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
EP1458360B1 (de) | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonale verabreichung von aminoglykosiden |
ATE385193T1 (de) | 2002-03-20 | 2008-02-15 | Mannkind Corp | Inhalationsgerät |
CA2423712A1 (en) | 2003-03-26 | 2004-09-26 | Nicolas Nourry | Crosslinked amylopectin by reactive extrusion and its use as an absorbent or superabsorbent material |
US7648982B2 (en) * | 2003-02-28 | 2010-01-19 | Ym Biosciences Inc. | Opioid delivery system |
KR20050114221A (ko) * | 2003-02-28 | 2005-12-05 | 데렉스 쎄라퓨틱스 인코포레이티드 | 오피오이드 전달 시스템 |
AU2004316339A1 (en) * | 2003-02-28 | 2005-09-09 | Ym Biosciences Inc. | Opioid delivery system |
US7648981B2 (en) * | 2003-02-28 | 2010-01-19 | Ym Biosciences Inc. | Opioid delivery system |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
US20070053843A1 (en) * | 2003-10-28 | 2007-03-08 | Dawson Michelle L | Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
KR101233564B1 (ko) * | 2003-11-14 | 2013-02-15 | 추가이 세이야쿠 가부시키가이샤 | 가교 다당 미립자 및 그 제조 방법 |
JP2007535389A (ja) | 2004-04-30 | 2007-12-06 | オーバスネイク メディカル インコーポレーテッド | 遺伝子的に改変された細胞を捕捉する被覆を備えた医療デバイスおよびその使用方法 |
WO2005116130A1 (en) * | 2004-05-27 | 2005-12-08 | Novozymes Biopolymer A/S | A fast dissolving dried hyaluronic acid product |
AU2005277208B2 (en) | 2004-08-20 | 2011-11-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
DK1791542T3 (en) | 2004-08-23 | 2015-06-15 | Mannkind Corp | Diketopiperazinsalte for pharmaceutical delivery |
BRPI0615819B8 (pt) | 2005-09-14 | 2021-05-25 | Mannkind Corp | processo para preparar uma composição de distribuição de fármaco compreendendo um agente ativo e uma micropartícula fumaril dicetopiperazina cristalina. |
SE529040C2 (sv) * | 2006-01-18 | 2007-04-17 | Bows Pharmaceuticals Ag | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin |
CN101389348A (zh) | 2006-02-22 | 2009-03-18 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
AU2007285472B2 (en) * | 2006-03-30 | 2013-10-24 | Engene, Inc. | Non-viral compositions and methods for transfecting gut cells in vivo |
GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
EP2197429B9 (de) * | 2007-09-03 | 2016-10-26 | Nanotherapeutics, Inc. | Teilchenzusammensetzung zur abgabe von schwerlöslichen arzneimitteln |
EP2077132A1 (de) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung |
CA3086027C (en) | 2008-06-13 | 2022-05-17 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
MX2010014240A (es) | 2008-06-20 | 2011-03-25 | Mankind Corp | Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion. |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US20100183687A1 (en) * | 2009-01-22 | 2010-07-22 | Cox D Phillip | Process for preparing particles of opioids and compositions produced thereby |
KR20110104120A (ko) | 2009-01-26 | 2011-09-21 | 테바 파마슈티컬 인더스트리즈 리미티드 | 극미립자를 이용한 담체 코팅 방법 |
DK2405963T3 (da) | 2009-03-11 | 2013-12-16 | Mannkind Corp | Apparat, system og fremgangsmåde til at måle modstand i en inhalator |
EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
WO2010144789A2 (en) | 2009-06-12 | 2010-12-16 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
PE20130036A1 (es) | 2009-11-25 | 2013-02-03 | Boehringer Ingelheim Int | Nebulizador |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
JP5874724B2 (ja) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
WO2012135765A2 (en) | 2011-04-01 | 2012-10-04 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
MX2014004983A (es) | 2011-10-24 | 2014-09-22 | Mannkid Corp | Metodos y composiciones para tratar dolor. |
WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
CN104394846B (zh) * | 2012-05-03 | 2018-10-19 | 爱尔兰詹森科学公司 | 用于治疗上呼吸道感染的聚肌苷酸-聚胞苷酸(聚(i:c))配制品 |
CN104619369B (zh) | 2012-07-12 | 2018-01-30 | 曼金德公司 | 干粉药物输送系统和方法 |
JP2015530361A (ja) * | 2012-07-13 | 2015-10-15 | タフツ・ユニバーシティ | 絹フィブロイン生体材料における非混和性の相の封入 |
EP2911690A1 (de) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalierbare influenza-impfstoffzusammensetzungen und verfahren |
US20140194378A1 (en) * | 2013-01-09 | 2014-07-10 | Dermal Research Laboratories, Inc. | Methods of Preventing or Treating Diseases and Conditions Using Complex Carbohydrates |
WO2014144895A1 (en) | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
JP6491658B2 (ja) | 2013-07-18 | 2019-03-27 | マンカインド コーポレイション | 熱安定性乾燥粉末医薬組成物及び方法 |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
PL2835146T3 (pl) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizator |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
CN106255554B (zh) | 2014-05-07 | 2021-05-04 | 勃林格殷格翰国际有限公司 | 容器、喷雾器及用途 |
DK3139984T3 (da) | 2014-05-07 | 2021-07-19 | Boehringer Ingelheim Int | Forstøver |
ES2957901T3 (es) | 2014-05-07 | 2024-01-29 | Boehringer Ingelheim Int | Recipiente y dispositivo indicador y nebulizador |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
BR112017008923A2 (pt) | 2014-10-31 | 2017-12-26 | Glaxosmithkline Ip Dev Ltd | ?formulação em pó? |
PT116887B (pt) * | 2015-04-29 | 2022-03-09 | Univ Do Algarve | Processo para a produção de micropartículas de polissacáridos direcionadas para os macrófagos alveolares, obtenção das micropartículas e uso das mesmas |
CN108096213B (zh) * | 2017-12-25 | 2020-06-30 | 河北科技大学 | 羟乙基淀粉130/0.4包裹辛伐他汀微球的制备方法 |
CA3144299A1 (en) * | 2019-07-02 | 2021-01-07 | F. Hoffmann-La Roche Ag | Process for the preparation of high water affinity type products with controlled humidity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9202464D0 (en) * | 1992-02-05 | 1992-03-18 | Danbiosyst Uk | Composition for nasal administration |
AU659328B2 (en) * | 1992-06-12 | 1995-05-11 | Teijin Limited | Ultrafine powder for inhalation and production thereof |
JP3266685B2 (ja) * | 1993-02-17 | 2002-03-18 | ブラザー工業株式会社 | プリンタ |
HUT77777A (hu) * | 1994-08-04 | 1998-08-28 | Quadrant Holdings Cambridge Limited | Szilárd vivőrendszerek molekulák kontrollált kibocsátására és eljárások a vivőrendszerek előállítására |
PL319600A1 (en) * | 1994-09-29 | 1997-08-18 | Andaris Ltd | Spray-dried microparticles as therapeutic carriers |
-
1996
- 1996-03-23 GB GBGB9606188.2A patent/GB9606188D0/en active Pending
-
1997
- 1997-03-24 EP EP97908411A patent/EP0895473B1/de not_active Expired - Lifetime
- 1997-03-24 DK DK97908411T patent/DK0895473T3/da active
- 1997-03-24 PT PT97908411T patent/PT895473E/pt unknown
- 1997-03-24 CA CA002250053A patent/CA2250053A1/en not_active Abandoned
- 1997-03-24 GB GB9818593A patent/GB2325162B/en not_active Expired - Fee Related
- 1997-03-24 WO PCT/GB1997/000808 patent/WO1997035562A1/en active IP Right Grant
- 1997-03-24 ES ES97908411T patent/ES2168609T3/es not_active Expired - Lifetime
- 1997-03-24 AU AU20384/97A patent/AU718593B2/en not_active Ceased
- 1997-03-24 DE DE69709722T patent/DE69709722T2/de not_active Expired - Fee Related
- 1997-03-24 NZ NZ331359A patent/NZ331359A/xx unknown
- 1997-03-24 AT AT97908411T patent/ATE209030T1/de not_active IP Right Cessation
- 1997-03-24 US US09/155,235 patent/US20010007665A1/en not_active Abandoned
- 1997-03-24 JP JP09534130A patent/JP2000510100A/ja active Pending
-
1998
- 1998-09-21 NO NO984376A patent/NO984376D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1997035562A1 (en) | 1997-10-02 |
EP0895473A1 (de) | 1999-02-10 |
AU2038497A (en) | 1997-10-17 |
CA2250053A1 (en) | 1997-10-02 |
GB9606188D0 (en) | 1996-05-29 |
NO984376L (no) | 1998-09-21 |
PT895473E (pt) | 2002-05-31 |
US20010007665A1 (en) | 2001-07-12 |
EP0895473B1 (de) | 2001-11-21 |
DK0895473T3 (da) | 2002-05-21 |
AU718593B2 (en) | 2000-04-20 |
GB2325162B (en) | 2000-02-23 |
DE69709722T2 (de) | 2002-08-14 |
GB9818593D0 (en) | 1998-10-21 |
ES2168609T3 (es) | 2002-06-16 |
NZ331359A (en) | 2000-09-29 |
NO984376D0 (no) | 1998-09-21 |
JP2000510100A (ja) | 2000-08-08 |
ATE209030T1 (de) | 2001-12-15 |
GB2325162A (en) | 1998-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69709722D1 (de) | Mikrokugeln aus polysaccharid zur pulmonaren wirkstoffabgabe | |
PL339568A1 (en) | Pharmacological compositions of masked inherent taste | |
SE9700135D0 (sv) | New formulation | |
EE9700132A (et) | Inhalatsiooniseade, meetod farmatseutilise toimeaine pihustamiseks ning meetod farmatseutilise toimeaine doosi manustamiseks | |
ATE239454T1 (de) | Orale morphinzubereitung in teilchenform | |
MY129356A (en) | Electrospun pharmaceutical compositions | |
ES2178943A1 (es) | Uso de compuestos organicos en el tratamiento de enfermedad pulmonar obstructiva cronica. | |
NO20012346L (no) | Törrpulver for inhalering | |
WO1996040086A3 (en) | Compositions and methods for topical administration of pharmaceutically active agents | |
DE60120648D1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
KR910004180A (ko) | 저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정 | |
ATE390915T1 (de) | Sprühgetrocknete insulin-mikropartikel zur inhalation | |
NO995127D0 (no) | Stabiliserte tibolonblandinger | |
GR3036384T3 (en) | Medicament form for the delivery of collagenase to wounds and process for the preparation thereof | |
DE69827466D1 (de) | Geschmacksneutrale pharmazeutische zusammensetzungen | |
DK0885010T3 (da) | Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle | |
WO2003105811A8 (en) | PROGRESSIVE RELEASE COMPOSITIONS AND METHOD OF USE | |
RU98110721A (ru) | Состав и способ получения геля димексида | |
ME00003B (me) | Perforisane mikročestice i postupci za njihovu primjenu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |